Gay pill
(SYDNEY, Thursday 21 November 2019) A modern study from the Kirby Institute at UNSW Sydney published today shows that gay and pansexual men who are taking the HIV prevention medication PrEP (pre-exposure prophylaxis) also have significantly bring down levels of HIV-related anxiety.
HIV transmission anxiety has affected sexual behaviours of lgbtq+ and bisexual men for more than 30 years, but this new explore provides the strongest evidence globally to suggest that alongside driving down HIV infection rates, PrEP may be strengthening the mental health and wellbeing of gay and pansexual men.
PrEP was made available in Australia through the Pharmaceutical Benefits Scheme in April 2018. When taken as directed, the medication prevents an HIV negative person from acquiring HIV.
Phillip Keen from the Kirby Institute, co-lead author on the paper, said this research has important implications for our understanding of the benefits of PrEP. “We’ve acknowledged for some period that PrEP is very good at protecting people from HIV. This recent evidence suggests that another benefit of taking PrEP is improved mental health, through reduced anxiety about HIV,” said Mr Keen.
The researchers analysed data from the Foll
CDC recommends morning-after pill to fight STIs in gay, gender diverse populations
Guidelines for using an antibiotic morning-after pill to curb sexually transmitted infections are on the horizon, as US health officials plan to endorse the proposed regulations.
On Monday, the Centers for Disease Control and Prevention released proposed guidelines for the apply of doxycycline post-exposure prophylaxis to decrease bacterial infections, like chlamydia, gonorrhea and syphilis, in populations that are most at risk.
The treatment, dubbed Doxy PEP — 200 milligrams taken once within 72 hours of unprotected sexual contact followed by routine screening — would only be considered for gay or bisexual men and transgender women who either own contracted at least one STI in the past year or who are at higher peril of infection.
“Doxy PEP is moving STI prevention efforts into the 21st Century,” Dr. Jonathan Mermin, the director of the CDC’s National Center for HIV, Viral Hepatitis, STD and TB Prevention, told The Post in a utterance.
“We need game-changing innovations to turn the STI epidemic around, and this is a major step in the right direction.”
Evidence that doxycycline post
PrEP
Prevent HIV with PrEP
PrEP (short for Pre-Exposure Prophylaxis) allows you to take direct of your sexual health and wellness. PrEP is a prevention method for people who are HIV-negative, but are vulnerable to getting HIV. When taken daily, PrEP is up to 99% effective at preventing new HIV infections.
PrEP is a key part of preventing new HIV infections, but does not block STDs/STIs love gonorrhea and chlamydia. Only condoms can do that.
Interested in getting on PrEP? Contact our team!
What is PrEP?
PrEP is an FDA-approved, CDC recommended daily prevention pill for HIV-negative individuals who are vulnerable to getting HIV. Taken daily, PrEP is up to 99% efficient at preventing unused HIV infections. Many people who obtain PrEP report feeling a sense of peace of brain while having sex, because they are taking their health into their hold hands. That calm of mind reduces the fear and stigma associated with HIV.
PrEP is about self-determination. It is a tool that gives you the power to dominate your health. PrEP can be prescribed as Truvada or Descovy for homosexual and bisexual men, heterosexual men and women, for trans+ and gender nonconforming folks. PrEP is for
PrEP: The small blue pill helping end HIV transmission
Access to a preventative drug has led to a fall in the number of gay and bisexual men diagnosed with HIV, a leading sexual health clinic has said.
Health Security Agency (HSA) figures for London show the number of first diagnoses had fallen in this group by 3% from 2021 to 2022.
Pre-Exposure Prophylaxis (PrEP) is a "powerful tool" in termination transmission, 56 Dean Avenue clinic said.
However there was a rise of 17% in new HIV diagnoses in the capital.
The treatment which has been free on the NHS in England since 2020, involves taking the PrEP pill containing the drugs tenofovir and emtricitabine before having sex.
Uptake of the drug has been greatest in gay and fluid men, the clinic said.
Consultant Dr Alan McOwan said: "Everyone should know about PrEP and its potential for preventing HIV."
He encouraged anyone considered at higher chance of HIV to enquire about it at their local sexual health clinic.
Across England however, among same-sex attracted and bisexual men, the overall reduced HIV transmission is not reflected across all ethnic groups.
Ta